Go Deep
Serina Therapeutics, Inc.
Serina Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,923 | -1.0 | 2.43 | 0.20 | 169.54 |
| Oct 2026 | 23,037 | -0.9 | 2.33 | 0.20 | 162.91 |
| Oct 2026 | 21,351 | -0.9 | 2.24 | 0.20 | 156.45 |
| Oct 2026 | 21,335 | -0.9 | 2.25 | 0.20 | 157.40 |
| Oct 2026 | 21,156 | -0.9 | 2.40 | 0.20 | 167.41 |
| Oct 2026 | 21,172 | -0.9 | 2.39 | 0.20 | 166.13 |
Serina Therapeutics, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -6,356,000.0 | -6,898,000.0 | -3,336,000.0 | -4,585,000.0 |
| EPS | -0.6 | -0.6 | — | -0.5 |
Serina Therapeutics, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 3,000,000.0 | 500,000.0 | — |
| Net Profit | -19,182,000.0 | -11,141,000.0 | 5,269,000.0 | -2,682,108.0 | — |
| EPS | -1.9 | -1.5 | 0.6 | -1.2 | — |
Serina Therapeutics, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 6,951,000.0 | 6,724,000.0 | 8,968,000.0 | 858,042.0 | — |
| Total Liabilities | 6,988,000.0 | 6,216,000.0 | 41,262,000.0 | 38,636,203.0 | — |
| Total Equity | -37,000.0 | 641,000.0 | -32,294,000.0 | -37,778,161.0 | — |
Owes vs Owns
Serina Therapeutics, Inc. owed $0.27 for every $1 it owned in Jun 2026, down from $45.0 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.27× | 1.01× | 0.92× | 4.60× | 45.0× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Serina Therapeutics, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 68.7%Fixed assets (tangible) 12.1%Other assets 19.2%
How it's funded — Dec 2025
Long-term debt 42.2%Payables 27.6%Other liabilities 30.2%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 4.8 | 3.7 | 7.6 | 0.5 |
| Receivables | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.8 | 1.0 | 1.3 | 0.3 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1.3 | 2.0 | 0.0 | 0.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.1 |
| Long-term debt | 2.9 | 0.3 | 3.0 | 1.6 |
| Payables | 1.9 | 0.7 | 0.6 | 0.1 |
| Other liabilities | 2.1 | 5.2 | 37.7 | 36.7 |
| Shareholders' equity | -0.0 | 0.5 | -32.3 | -37.8 |
| Net tangible assets | -0.0 | 0.6 | -32.3 | -37.8 |
Serina Therapeutics, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -17,955,000.0 | -17,137,000.0 | -2,476,000.0 | -2,075,624.0 | — |
| Investing Activities | -59,000.0 | -22,000.0 | -504,000.0 | 980,937.0 | — |
| Financing Activities | 17,412,000.0 | 13,212,000.0 | 10,067,000.0 | 1,312,070.0 | — |